The genomics revolution has brought personalised medicine to cancer and rare diseases, but cardiovascular care is stuck in the past. An EU-funded initiative aims to change that

The Paediatric Regulation has “basically forced” companies to tailor drugs for use by children, but more work is needed to plug gaps in the area of childhood rare diseases

Unlike hip replacements or cataract surgery, treating mental health conditions can be open-ended - and assessing outcomes subjective. But now there is a push to develop standards and enable mental health to join the value-based healthcare revolution   

More than a year after the public consultation closed, EMA and the Commission have announced moves that aim to clear the regulatory logjam holding back commercialisation of therapies based on tissues, cells and genes

The apps will improve self-care, adherence to therapy and long-term outcomes in this common, chronic condition, its developers say. The app for healthcare professionals will be one of the first such m-health apps to be CE-approved

Fears that the EU will give up its involvement in health won’t go away. A big concern is that the next president of the Commission “might abolish” its responsibilities, says Austria’s director-general for health

Public-private drug research programme has - as yet - only provided limited examples of how it is delivering on its goals, an independent evaluation concludes